Ian F Pollack Selected Research

gallium arsenide (GaAs)

12/2016	Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.
1/2016	Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.
7/2014	Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem and nonbrainstem gliomas.
7/2008	Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian F Pollack Research Topics

Disease

110	Glioma (Gliomas) 01/2024 - 02/2002
96	Neoplasms (Cancer) 01/2024 - 02/2002
38	Brain Neoplasms (Brain Tumor) 08/2022 - 03/2002
20	Medulloblastoma 11/2021 - 12/2007
19	Glioblastoma (Glioblastoma Multiforme) 01/2023 - 09/2002
13	Hydrocephalus (Hydrocephaly) 05/2024 - 09/2004
9	Craniosynostoses (Craniosynostosis) 05/2024 - 01/2010
8	Central Nervous System Neoplasms 01/2022 - 08/2004
8	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 08/2005
7	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 06/2012
6	Infections 05/2024 - 01/2021
6	Ependymoma 01/2019 - 08/2011
5	Diffuse Intrinsic Pontine Glioma 01/2023 - 04/2011
5	Primitive Neuroectodermal Tumors (PNET) 10/2018 - 08/2006
4	Hemorrhage 01/2021 - 09/2004
4	Hypoxia (Hypoxemia) 06/2016 - 09/2004
3	Intracranial Hypertension 02/2016 - 08/2011
3	Melanoma (Melanoma, Malignant) 11/2013 - 08/2004
3	Disease Progression 10/2013 - 07/2008
2	Brain Injuries (Brain Injury) 05/2024 - 01/2021
2	Synostosis 06/2021 - 01/2010
2	Craniopharyngioma (Craniopharyngiomas) 11/2020 - 12/2012
2	Arnold-Chiari Malformation (Arnold-Chiari Syndrome) 10/2019 - 10/2013
2	Syringomyelia (Morvan's Disease) 10/2019 - 10/2013
2	Neurofibromatoses (Neurofibromatosis) 01/2019 - 01/2017
2	Exanthema (Rash) 01/2019 - 08/2017
2	Edema (Dropsy) 12/2017 - 09/2004

Drug/Important Bio-Agent (IBA)

16	AntigensIBA 12/2022 - 02/2002
14	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
13	VaccinesIBA 02/2017 - 06/2002
11	Peptides (Polypeptides)IBA 02/2017 - 09/2002
10	Temozolomide (Temodar)FDA LinkGeneric 01/2024 - 06/2003
9	EpitopesIBA 12/2016 - 09/2002
8	dipinacoline glutamateIBA 01/2023 - 04/2011
8	Carboplatin (JM8)FDA LinkGeneric 09/2021 - 12/2008
7	Histones (Histone)IBA 12/2023 - 12/2005
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2002
7	EnzymesIBA 01/2022 - 03/2005
7	SurvivinIBA 01/2017 - 07/2008
6	Small Interfering RNA (siRNA)IBA 01/2022 - 12/2009
6	ParaffinIBA 08/2019 - 02/2002
5	Bevacizumab (Avastin)FDA Link 01/2024 - 01/2013
5	Phosphotransferases (Kinase)IBA 12/2023 - 12/2005
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 02/2002
5	Bortezomib (Velcade)FDA Link 01/2023 - 01/2011
5	Histone Deacetylase InhibitorsIBA 01/2023 - 12/2005
5	Lysine (L-Lysine)FDA Link 01/2022 - 04/2009
5	ABT-737IBA 01/2015 - 06/2012
4	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 06/2022
4	Protein Subunit VaccinesIBA 12/2022 - 01/2013
4	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2022 - 09/2004
4	LigandsIBA 01/2021 - 01/2011
4	InterferonsIBA 11/2020 - 08/2004
4	Formaldehyde (Formol)FDA Link 08/2019 - 03/2011
4	gallium arsenide (GaAs)IBA 12/2016 - 07/2008
4	Lomustine (CCNU)FDA Link 10/2016 - 09/2003
4	ErbB Receptors (EGF Receptor)IBA 02/2016 - 09/2005
4	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 08/2005
4	Alkylating AgentsIBA 12/2012 - 07/2006
4	CytokinesIBA 10/2011 - 10/2004
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 10/2009 - 01/2006
3	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2024 - 12/2013
3	Adenosine Triphosphate (ATP)IBA 01/2023 - 12/2005
3	AZD 6244IBA 08/2022 - 08/2017
3	Methionine (L-Methionine)FDA Link 07/2022 - 01/2018
3	NucleotidesIBA 11/2021 - 10/2019
3	Isotretinoin (Accutane)FDA LinkGeneric 09/2021 - 06/2003
3	Proteasome InhibitorsIBA 01/2020 - 01/2011
3	Mitogen-Activated Protein KinasesIBA 08/2017 - 12/2006
3	sepantroniumIBA 01/2017 - 03/2013
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 02/2016 - 01/2006
3	TensinsIBA 02/2016 - 01/2006
3	Vincristine (Oncovin)FDA LinkGeneric 01/2016 - 09/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2015 - 01/2011
3	CaspasesIBA 01/2015 - 05/2002
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2014 - 01/2006
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 12/2006
3	tipifarnib (R115777)IBA 04/2011 - 12/2007
3	Gefitinib (Iressa)FDA Link 04/2011 - 05/2006
3	tanespimycin (17AAG)IBA 09/2008 - 01/2006
3	Interleukin-4 (Interleukin 4)IBA 12/2007 - 08/2003
2	Vorinostat FDA Link 01/2024 - 02/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2013
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2013
2	PanobinostatIBA 01/2023 - 01/2020
2	Aurora KinasesIBA 01/2022 - 01/2015
2	dinaciclibIBA 01/2018 - 02/2016

Therapy/Procedure

58	Therapeutics 12/2022 - 03/2002
32	Drug Therapy (Chemotherapy) 12/2023 - 06/2002
28	Radiotherapy 12/2022 - 08/2002
14	Immunotherapy 01/2023 - 08/2003
8	Sutures (Suture) 05/2024 - 01/2010
8	Craniotomy 07/2020 - 07/2002
6	Ventriculostomy 02/2024 - 06/2020
5	Catheters 05/2024 - 06/2022
4	Ventriculoperitoneal Shunt 01/2023 - 08/2015
4	Decompression 10/2019 - 04/2007
3	Cautery 04/2022 - 06/2020
3	Craniospinal Irradiation 01/2016 - 01/2010
2	Cerebrospinal Fluid Shunts 01/2024 - 09/2023